Typhoid Fever

Typhoid fever is a life-threatening illness caused by the bacterium Salmonella Typhi. Typhoid fever is still common in the developing world, where it affects about 21.5 million persons each year.
What is Typhoid?

Typhoid fever is an infection caused by a strain of bacteria called Salmonella typhii, which is related to the bacteria that causes salmonella food poisoning. The infection can affect the whole body and damage multiple organs. Unless treated, this infection can have life threatening consequences.

Read More

Overview

Feature Articles

Latest Typhoid Fever News and Research

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Drug-resistant typhoid needs to be treated as a global problem

Drug-resistant typhoid needs to be treated as a global problem

Bacteria causing typhoid fever are highly developing antibiotic resistance

Bacteria causing typhoid fever are highly developing antibiotic resistance

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

COVID-19 first wave increased the sale of antibiotic formulations in India

COVID-19 first wave increased the sale of antibiotic formulations in India

Role of traditional medicine against SARS-CoV-2

Role of traditional medicine against SARS-CoV-2

Covid strikes clergy as they comfort pandemic’s sick and dying

Covid strikes clergy as they comfort pandemic’s sick and dying

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

Antimicrobial resistance to critical drugs spirals in low- and middle-income countries

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

MARA project aims to use new DNA based nanotechnology to fight bacteria

MARA project aims to use new DNA based nanotechnology to fight bacteria

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Lymphopenia may hint a higher risk of future illness, death

Lymphopenia may hint a higher risk of future illness, death

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

UMSOM researchers to test the safety, tolerability of prototype Shigella-ETEC vaccine

UMSOM researchers to test the safety, tolerability of prototype Shigella-ETEC vaccine

UMSOM receives landmark contract from NIAID for influenza research

UMSOM receives landmark contract from NIAID for influenza research

Researchers study typhoid genomes of travelers from different parts of the world

Researchers study typhoid genomes of travelers from different parts of the world

Scientists reveal how typhoid toxin works to accelerate aging of cells

Scientists reveal how typhoid toxin works to accelerate aging of cells

New study launched in Burkina Faso to test typhoid conjugate vaccine

New study launched in Burkina Faso to test typhoid conjugate vaccine

Genome research suggests presence of enteric fever in medieval Europe

Genome research suggests presence of enteric fever in medieval Europe